Retinal Changes in Alzheimer's disease (AD) Correlated with Cerebral Amyloid Staging, A Promising Early Biomarker in AD

Project: Research project

Project Details

Description

This study will validate in-vivo retinal hyperspectral imaging (HSI) as biomarker in preclinical human AD and elucidate the neuropathologic sequence of Aβ evolutional changes in preclinical to late stage AD in post-mortem tissue.
StatusActive
Effective start/end date11/16/2011/16/23

Funding

  • Retispec, Inc. (Agmt 11/16/20)
  • Alzheimer's Drug Discovery Foundation (Agmt 11/16/20)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.